Part 10/16:
Beyond performance enhancement, Musk sees immediate benefits in treating neurological disorders. Neuralink has received FDA breakthrough device designation for conditions like blindsight—a form of residual visual perception without consciousness—highlighting potential for restoring sight. He expressed optimism about applying BCIs to a broad spectrum of neurodegenerative diseases, psychiatric conditions, and neurodiverse illnesses.
For individuals with paralysis or spinal cord injuries, Neuralink could re-establish communication pathways—bridging severed nerves and restoring motor control. Essentially, this technology could reanimate the body by rerouting signals around damaged pathways, offering hope for millions.